DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,243,585 | +99466.5% | 4,977 | -1.7% | 0.09% | -7.5% |
Q1 2024 | $1,249 | +20.4% | 5,062 | +12.5% | 0.09% | +10.7% |
Q4 2023 | $1,037 | -41.5% | 4,500 | -37.6% | 0.08% | -44.4% |
Q3 2023 | $1,773 | +16.9% | 7,216 | +13.4% | 0.15% | +17.1% |
Q2 2023 | $1,517 | -28.5% | 6,366 | -23.5% | 0.13% | -34.5% |
Q1 2023 | $2,121 | -4.7% | 8,326 | -0.5% | 0.20% | -12.8% |
Q4 2022 | $2,225 | -99.9% | 8,366 | +6.2% | 0.23% | +0.9% |
Q3 2022 | $2,043,000 | +37.1% | 7,878 | +55.1% | 0.22% | +34.9% |
Q1 2022 | $1,490,000 | +30.8% | 5,080 | +47.3% | 0.17% | +21.2% |
Q4 2021 | $1,139,000 | +20.7% | 3,448 | +11.5% | 0.14% | +10.5% |
Q3 2021 | $944,000 | +20.9% | 3,093 | +6.3% | 0.12% | +6.9% |
Q2 2021 | $781,000 | +39.0% | 2,909 | +16.8% | 0.12% | -8.7% |
Q1 2021 | $562,000 | -12.5% | 2,490 | -13.5% | 0.13% | -0.8% |
Q4 2020 | $642,000 | -2.3% | 2,879 | -5.7% | 0.13% | -11.7% |
Q3 2020 | $657,000 | +38.6% | 3,053 | +13.9% | 0.14% | +12.4% |
Q2 2020 | $474,000 | +38.2% | 2,680 | +7.8% | 0.13% | +26.5% |
Q1 2020 | $343,000 | -44.5% | 2,487 | -38.2% | 0.10% | -41.7% |
Q4 2019 | $618,000 | +5.1% | 4,025 | -0.9% | 0.18% | -10.7% |
Q3 2019 | $588,000 | +5.2% | 4,062 | +4.1% | 0.20% | +8.9% |
Q2 2019 | $559,000 | +138.9% | 3,901 | +121.3% | 0.18% | +122.2% |
Q1 2019 | $234,000 | +18.2% | 1,763 | -7.8% | 0.08% | 0.0% |
Q4 2018 | $198,000 | -2.5% | 1,913 | +2.5% | 0.08% | +6.6% |
Q3 2018 | $203,000 | +9.1% | 1,866 | 0.0% | 0.08% | +18.8% |
Q2 2018 | $186,000 | +21.6% | 1,866 | +19.8% | 0.06% | -15.8% |
Q1 2018 | $153,000 | +106.8% | 1,557 | +95.6% | 0.08% | +153.3% |
Q4 2017 | $74,000 | +8.8% | 796 | 0.0% | 0.03% | -9.1% |
Q3 2017 | $68,000 | +6.2% | 796 | +4.3% | 0.03% | +3.1% |
Q2 2017 | $64,000 | -1.5% | 763 | 0.0% | 0.03% | -8.6% |
Q1 2017 | $65,000 | +10.2% | 763 | 0.0% | 0.04% | +2.9% |
Q4 2016 | $59,000 | -1.7% | 763 | 0.0% | 0.03% | -10.5% |
Q3 2016 | $60,000 | -22.1% | 763 | 0.0% | 0.04% | -29.6% |
Q2 2016 | $77,000 | +4.1% | 763 | -1.8% | 0.05% | 0.0% |
Q1 2016 | $74,000 | +2.8% | 777 | 0.0% | 0.05% | +14.9% |
Q4 2015 | $72,000 | – | 777 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |